Main Article Content

Practolol in Hyperthyroid Cardiac Failure


S. Epstein
B Pimstone

Abstract

Practolol (Eraldint), a recently developed beta-adrenergic blocking agent, has been found useful in conjunction with digitalis and diuretics in 6 patients with thyrocardiac disease who had been refractory to therapy. In all cases cardiac failure improved dramatically, suggesting better myocardial efficiency and a return of digitalis responsiveness after practolol. This drug might be a useful therapeutic adjunct in thyrocardiac disease.


Journal Identifiers


eISSN: 2078-5135
print ISSN: 0256-9574